REFERENCE
UK MHRA.Orlistat safety update. Drug Safety Update 3: 4-5, No. 7, Feb 2010
Rights and permissions
About this article
Cite this article
A European review of orlistat has concluded that there is insufficient evidence to show that the drug is associated with more serious liver disorders. React. Wkly. 1288, 4 (2010). https://doi.org/10.2165/00128415-201012880-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-201012880-00008